Adgang til aktieinformation, aktienyheder, selskabsledelser og analytikere.

We continue to see strong long-term growth and value creation potential for the company, and the share valuation has moderated as well.

31:45

Jukka Tapaninen, CEO, talks about medical software company Aiforia as an investment.

I dagens Morgenbørs ser vi ind i flade europæiske futures, Oracle skaber usikkerhed om AI. Herhjemme fokus på blandt andet Nilfisk der har fået et overtagelsesbud og Zealand (CMD).

Dagens aktienyheder med GreenMobility A/S

Scanfil announced on Tuesday evening that it had completed the acquisition of US electronics contract manufacturer ADCO Circuits. We believe ADCO is a good strategic fit for Scanfil, and the valuation of the arrangement is also moderate, so the value creation potential of the rather small transaction seems promising.

The share issue was expected, although it took place slightly earlier than we predicted, was smaller, and at a slightly lower valuation.

Taaleri's guarantee insurance company Garantia announced on Wednesday that it completed its first credit risk insurance project outside Finland during the fall.

Pharma Equity Group (PEG) has taken the first tangible step in executing its diversification strategy announced in May 2025 by signing a Letter of Intent (LOI) to acquire Otiom A/S, a Danish MedTech company specializing in IoT-based localization technology for people with dementia. The transaction marks PEG’s initial expansion beyond pharmaceuticals into commercial-stage MedTech and aligns with CEO Christian Tange’s (new CEO from 1 April 2025) ambition to become a Nordic life sciences consolidator.

17:27

Kari Vyhtinen, CEO, talks about mining and exploration company Endomines as an investment.

The rapid sales growth is attributable to the record-fast expansion of the store network and moderate like-for-like growth.

I dagens Morgenbørs ser vi ind i røde europæiske futures forud for dagens FED-møde. Herhjemme er der fokus på blandt andet Ambu, Grønlandsbanken, ISS, Roblon og en række nye kursmål.

Dagens aktienyheder med GrønlandsBANKEN, ISS og Roblon

28:25

Antti Vuolanto, CEO, talks about biotechnology company Herantis Pharma as an investment.

27:26

Tuukka Hirvonen, Head of Investor Relations, talks about pharmaceutical company Orion as an investment.

14:40

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Roblon har her til formiddag udsendt foreløbige tal for de fortsættende aktiviteter for årsregnskabet 2024/25, der dækker perioden 1. november 2024 til 31. oktober 2025, og som efter planen udsendes i sin fulde version – torsdag d. 18. december 2025. Samtidig løfter Roblon sløret for forventningerne til regnskabsåret 2025/26.

I dagens Morgenbørs ser vi ind i flade Europæiske futures, renter stiger forud for FED møde. Herhjemme fokus på blandt andet Sydbank, Ørsted, Novo